• Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1989 …2020

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

S. Ishii

  • Mitsubishi Chemical Corporation
  • Mitsubishi Chemical Co.
  • Yokohama Research Center

External person

Fujio Suzuki

  • Osaka University
  • Department of Biochemistry and Calcified-Tissue Metabolism

External person

P. S. Widdowson

  • University of Liverpool
  • Department of Medicine

External person

G. Williams

  • Department of Medicine
  • University of Liverpool

External person

Chieko Minami

  • Mitsubishi Chemical Corporation
  • Yokohama Research Center

External person

Mitchell A. Lazar

  • University of Pennsylvania
  • Div. Endocrinol., Diabet., Metab.
  • School of Medicine

External person

Mauricio J. Reginato

  • Harvard University
  • Div. Endocrinol., Diabet., Metab.
  • University of Pennsylvania
  • Dept. of Cell Biology

External person

T. Kataoka

  • Harvard University

External person

Li Sen Liu

  • Deutsches Diabetes-Zentrum

External person

R. Matsuda

  • The University of Tokyo
  • The University of Tokyo
  • Department of Biology

External person

Naoko Miyajima

  • National Institute of Infectious Diseases

External person

Hiroyuki Inoue

  • Department of Biochemistry and Calcified-Tissue Metabolism
  • Osaka University

External person

Hideaki Maekawa

  • National Institute of Health
  • National Institutes of Health, Bethesda
  • Division of Radiation Control and Biology
  • National Institute of Infectious Diseases

External person

Shannon T. Bailey

  • Univ. of Pennsylvania Sch. of Med.
  • University of Pennsylvania
  • Div. Endocrinol., Diabet., Metab.

External person

Akihito Kamizono

  • Research Center
  • Mitsubishi Chemical Corporation

External person

Jun Kondo

  • Mitsubishi Chemical Corporation

External person

Samuel L. Krakow

  • Univ. of Pennsylvania Sch. of Med.
  • University of Pennsylvania
  • Div. Endocrinol., Diabet., Metab.

External person

Keiichiro Masuda

  • Healthcare Business Development

External person

T. Tamaoki

  • Harvard University

External person

Teru Ogura

  • Kumamoto University
  • Department of Molecular Cell Biology, Institute of Molecular Embryology and Genetics

External person

Kazuhiro Okano

  • National Institute of Health
  • National Institutes of Health, Bethesda
  • Division of Radiation Control and Biology
  • National Institute of Infectious Diseases

External person

P. King

  • University of Liverpool
  • Department of Medicine

External person

Y. Yamawaki-Kataoka

  • Harvard University

External person

Jürgen Eckel

  • Diabetes Research Institute
  • Deutsches Diabetes-Zentrum
  • Molecular Cardiology

External person

R. Upton

  • University of Liverpool
  • Department of Medicine

External person

Yuji Hiraki

  • Osaka University
  • Department of Biochemistry and Calcified-Tissue Metabolism

External person

Susumu Izumi

  • Tokyo Metropolitan University
  • Department of Biology

External person

A. Nishikawa

  • The University of Tokyo
  • The University of Tokyo
  • Saitama Medical University
  • Department of Physiology

External person

Shiro Tomino

  • Tokyo Metropolitan University
  • Department of Biology

External person

Naoko Takada

  • National Institute of Health
  • National Institutes of Health, Bethesda
  • Division of Radiation Control and Biology
  • National Institute of Infectious Diseases

External person

Kozo Tsuchida

  • National Institute of Health
  • National Institutes of Health, Bethesda
  • Division of Radiation Control and Biology
  • National Institute of Infectious Diseases

External person

L. Pickavance

  • UCD
  • Department of Medicine
  • University of Liverpool
  • Diabet. and Endocrinol. Res. Group
  • UCD

External person

ryoichi matsuda

  • Tokyo University

External person

H. R. Choe

  • Harvard University

External person